Evidence map›Paper›PMID 22037357›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2012

Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids.

R Duncan Hite, Bonnie L Grier, B Moseley Waite, Ruud A Veldhuizen, Fred Possmayer, Li-Juan Yao, Michael C Seeds

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. sPLAScience advances · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Lung Organoids for Hazard Assessment of Nanomaterials.International journal of molecular sciences · 2022
    Article
  9. Article
  10. Review
  11. Group 1B phospholipase ABiochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Review
  12. Review
  13. Article
  14. IL-6 trans-signaling increases expression of airways disease genes in airway smooth muscle.American journal of physiology. Lung cellular and molecular physiology · 2015
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

R Duncan HiteSection Head-Pulmonary, Critical Care, Allergy and Immunologic Diseases, Wake Forest University School of Medicine, 1 Medical Ctr. Blvd., Winston-Salem, NC 27157-1054, USA. dhite@wfubmc.edu
Bonnie L Grier
B Moseley Waite
Ruud A Veldhuizen
Fred Possmayer
Li-Juan Yao
Michael C Seeds
ENT and Allergy · USLawson Health Research Institute · CAWake Forest University · USWestern University · CA

Funding

Phospholipase A2-mediated surfactant hydrolysis and dysfunction in ALI and ARDSR01HL085248 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HITE, ROBERT DUNCAN · 2007 to 2011
$1.8M
CIHRNHLBI NIH HHS R01 HL085248
6 · The paper itself

Abstract

Hydrolysis of surfactant phospholipids (PL) by secretory phospholipases A(2) (sPLA(2)) contributes to surfactant damage in inflammatory airway diseases such as acute lung injury/acute respiratory distress syndrome. We and others have reported that each sPLA(2) exhibits specificity in hydrolyzing different PLs in pulmonary surfactant and that the presence of hydrophilic surfactant protein A (SP-A) alters sPLA(2)-mediated hydrolysis. This report tests the hypothesis that hydrophobic SP-B also inhibits sPLA(2)-mediated surfactant hydrolysis. Three surfactant preparations were used containing varied amounts of SP-B and radiolabeled tracers of phosphatidylcholine (PC) or phosphatidylglycerol (PG): 1) washed ovine surfactant (OS) (pre- and postorganic extraction) compared with Survanta (protein poor), 2) Survanta supplemented with purified bovine SP-B (1-5%, wt/wt), and 3) a mixture of dipalmitoylphosphatidylcholine (DPPC), 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC), and 1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG) (DPPC:POPC:POPG, 40:40:20) prepared as vesicles and monomolecular films in the presence or absence of SP-B. Hydrolysis of PG and PC by Group IB sPLA(2) (PLA2G1A) was significantly lower in the extracted OS, which contains SP-B, compared with Survanta (P = 0.005), which is SP-B poor. Hydrolysis of PG and PC in nonextracted OS, which contains all SPs, was lower than both Survanta and extracted OS. When Survanta was supplemented with 1% SP-B, PG and PC hydrolysis by PLA2G1B was significantly lower (P < 0.001) than in Survanta alone. When supplemented into pure lipid vesicles and monomolecular films composed of PG and PC mixtures, SP-B also inhibited hydrolysis by both PLA2G1B and Group IIA sPLA2 (PLA2G2A). In films, PLA2G1B hydrolyzed surfactant PL monolayers at surface pressures ≤30 mN/m (P < 0.01), and SP-B lowered the surface pressure range at which hydrolysis can occur. These results suggest the hydrophobic SP, SP-B, protects alveolar surfactant PL from hydrolysis mediated by multiple sPLA(2) in both vesicles (alveolar subphase) and monomolecular films (air-liquid interface).

Indexed as

Acute Lung InjuryAnimalsCattleGroup IA Phospholipases A2Group IB Phospholipases A2HydrolysisHydrophobic and Hydrophilic InteractionsPhosphatidylcholinesPhosphatidylglycerolsPhospholipidsPulmonary Surfactant-Associated Protein APulmonary Surfactant-Associated Protein BPulmonary SurfactantsRespiratory Distress SyndromeSheepGroup IA Phospholipases A2Group IB Phospholipases A2PhosphatidylcholinesPhosphatidylglycerolsPhospholipidsPulmonary Surfactant-Associated Protein APulmonary Surfactant-Associated Protein BPulmonary Surfactants

Identifiers

PMID22037357
PMCPMC3349360
OpenAlexW2105122487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.